Biomedical firm in £1m expansion

A biomedical firm in the North announced a cash injection of around £1m (€1.05m) today to help expand the business.

Queen’s University spin-out company i-Path Diagnostics is a leader in the delivery of innovative software technologies for education, training and research in diagnostic medicine – particularly cancer research and detection.

Announcing the investment in the four-year-old company, chairman Ian Kerr said it had been built on the North's strong knowledge economy and internet connectivity.

Most Read in Business

  • Lufthansa slams Ryanair fare policy

    Lufthansa’s chief exeuctive has slammed as “irresponsible” Ryanair’s move to charge less than €10 for tickets on certain German routes, saying the airline won’t be pushed out of its home market.

  • Lufthansa slams Ryanair German growth strategy

    Lufthansa's chief executive has slammed as "irresponsible" Ryanair's move to charge less than €10 for tickets on certain German routes, saying the airline won't be pushed out of its home market.

  • Italy presses EU over rules

    Italy wants France and Spain to support its campaign to change the EU’s fiscal rules and focus them more on growth in the face of a regional and global economic slowdown, Economy Minister Giovanni Tria said in an interview.

  • ‘Operation Transformation’ producer puts on the profits

    The independent production firm behind RTÉ’s Operation Transformation TV show has increased profits fourfold.

  • Wicklow farmer has healthy oils market sussed out

    A unique plant oil blend has 11 times more Omega 3 than olive oil as well as the health benefits of fish oils.